Fig. 3: MiR-302a-3p and miR-3130-3p possessed binding sites for LINC01016 in endometrial cancer cells. | Cell Death & Disease

Fig. 3: MiR-302a-3p and miR-3130-3p possessed binding sites for LINC01016 in endometrial cancer cells.

From: LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis

Fig. 3: MiR-302a-3p and miR-3130-3p possessed binding sites for LINC01016 in endometrial cancer cells.

a Relative expression levels of miR-302a-3p/miR-3130-3p were determined with qRT-PCR after transfection with lentiviral constructs harboring LINC01016 (+), LINC01016 (−), and scrambled controls (NC). b Relative expression levels of LINC01016 by qRT-PCR after cells were transfected with agomir-302a-3p, antagomir-302a-3p, or NC. c Luciferase assays were carried out for miR-302a-3p/miR-3130-3p and LINC01016. Predicted miR-302a-3p/miR-3130-3p binding sites in LINC01016 and the designed mutant sequence are shown. Data are presented as the means ± SD from three independent experiments. *P < 0.05

Back to article page